Shattuck Labs, Inc. Board of Directors

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

Mr. Andrew R. Neill M.B.A.

Mr. Andrew R. Neill M.B.A.

Chief Financial Officer

Dr. Stephen Stout J.D., Ph.D.

Dr. Stephen Stout J.D., Ph.D.

General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer

Mr. George Fromm Ph.D.

Mr. George Fromm Ph.D.

Co-Chief Scientific Officer

Mr. Conor Richardson CPA

Mr. Conor Richardson CPA

Vice President of Investor Relations

Mr. Suresh de Silva Ph.D.

Mr. Suresh de Silva Ph.D.

Co-Chief Scientific Officer

Ms. Casi DeYoung

Ms. Casi DeYoung

Chief Business Officer

Dr. Thomas Lampkin Pharm.D.

Dr. Thomas Lampkin Pharm.D.

Senior Vice President of Regulatory Affairs

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.